On May 17, 2022, the Ministry of Health issues the Decision No. 1226/QD-BYT on promulgating the Guidelines on adjusting a number of provisions on screening, testing, and distributing the flow of patients with suspected SARS-CoV-2 infection, and receiving, treating COVID-19 patients in medical examination and treatment establishments.
Accordingly, SARS-CoV-2 testing shall be conducted for people visiting hospitals for medical examination, in-patients and health staff in case of showing symptoms of COVID-19 infection such as cough, fever, runny nose, sore throat, chest pain, dyspnoea, myalgia and loss of taste or smell, and other abnormal symptoms after COVID-19 screening.
Hospitals shall focus on assessing the risk and detecting symptoms of COVID-19 infection to designate testing for patients before performing surgery, patients in high-risk departments such as intensive care, stroke, haemodialysis (artificial kidney), postoperation departments and other patients at professional requirements.
Besides, patient and other objectives need to take SARS-CoV-2 testing as follows: Caregivers, persons providing services for hospitals, customers of hospitals, students.
Visitors who show symptoms of COVID-19 infection as mentioned above must actively go to the COVID-19 screening areas and comply with health staff’s instructions and indications.